Clinical Research Directory
Browse clinical research sites, groups, and studies.
Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure
Sponsor: Evi Liliek Wulandari
Summary
This study compares the effects of once-daily versus twice-daily ramipril dosing on renal function in chronic kidney disease (CKD) patients with heart failure with reduced ejection fraction (HFrEF). Outcomes include changes in plasma renin activity, malondialdehyde, interleukin-6, albuminuria, and cystatin C after 30 days of therapy.
Official title: Comparative Effects of Single Versus Twice-Daily Ramipril Dosing on Renal Function in Patients With Chronic Kidney Disease and Heart Failure With Reduced Ejection Fraction: Evaluation of Plasma Renin Activity, Malondialdehyde, Interleukin-6, Albuminuria, and Cystatin C
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2025-06-30
Completion Date
2026-01-31
Last Updated
2025-12-10
Healthy Volunteers
No
Interventions
Ramipril
Ramipril administered either as 10 mg once daily or 5 mg twice daily for 30 days
Locations (1)
UNS Hospital
Kartasura, Central Java, Indonesia